What is Coroflo?
Coroflo is pioneering the development of Coro, recognized as the world's first accurate breastfeeding monitor. This innovative device provides mothers with real-time data on breast milk intake, offering precise measurements of milk flow and volume. By empowering mothers with evidence-based insights, Coroflo aims to enhance the breastfeeding experience and support informed decisions. The company's commitment to innovation has been acknowledged with accolades such as the Red Dot Award for Innovation 2025, positioning it as a significant player in maternal health technology.
How much funding has Coroflo raised?
Coroflo has raised a total of $3M across 1 funding round:
Other Financing Round
$3M
Other Financing Round (2024): $3M, investors not publicly disclosed
What's next for Coroflo?
The recent major strategic investment signals a pivotal growth phase for Coroflo. This capital infusion is expected to fuel further product development, market expansion, and potentially enhance manufacturing capabilities. Coroflo's focus on a critical segment of the maternal health market, combined with its technological innovation, positions it for significant scaling and increased market penetration. Future endeavors will likely concentrate on solidifying its position as a leader in breastfeeding support technology.
See full Coroflo company page
